Cwm, LLC Foghorn Therapeutics Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Cwm, LLC holds 38 shares of FHTX stock, worth $306. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 17 123.53%

Holding current value

$306

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$4.8 - $9.99 $100 - $209	21 Added 123.53%	38 $0
Q2 2024 Jul 09, 2024	BUY	$5.05 - $8.0 $80 - $128	16 Added 1600.0%	17 $0
Q1 2024 Apr 05, 2024	BUY	$2.82 - $7.94 $2 - $7	1 New	1 $0

Others Institutions Holding FHTX

# of Institutions

Shares Held

32.7M

Call Options Held

Put Options Held

1.8K

Flagship Pioneering Inc. Cambridge, MA

12.7M
Shares

$102 Million
8.71% of portfolio
Bvf Inc San Francisco, CA

5.3M
Shares

$42.8 Million
0.93% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

2.52M
Shares

$20.3 Million
0.3% of portfolio
Raymond James & Associates St Petersburg, FL

2.3M
Shares

$18.5 Million
0.01% of portfolio
Euclidean Capital LLC New York, NY

1.57M
Shares

$12.7 Million
1.14% of portfolio

View Full List

About Foghorn Therapeutics Inc.

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $336M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

More about FHTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account